Enhancement of antitumor effects in vivo by the combination therapy with S-1 and Oxaliplatin in combination with radiation on a 5-FU resistant human colon cancer xenografts.

Eiko Nakata; Masakazu Fukushima; Kenji Nemoto; Yoshihiro Takai; Yoshihiro Ogawa; Kenji Takai; Tooru Sakayauchi; Keiichi Jinngu; Toshiyuki Sugawara; Kakutaro Narazaki

doi:10.11513/jrrsabst.2005.0.327.0

Enhancement of antitumor effects in vivo by the combination therapy with S-1 and Oxaliplatin in combination with radiation on a 5-FU resistant human colon cancer xenografts.

Identifier:nobleid.org/w1/20260515/EC8F68F5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EC8F68F5.svg?ark=w1%2F20260515%2FEC8F68F5)](https://nobleid.org/work/w1/20260515/EC8F68F5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Enhancement of antitumor effects in vivo by the combination therapy with S-1 and Oxaliplatin in combination with radiation on a 5-FU resistant human colon cancer xenografts.

Identifier:nobleid.org/w1/20260515/EC8F68F5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EC8F68F5.svg?ark=w1%2F20260515%2FEC8F68F5)](https://nobleid.org/work/w1/20260515/EC8F68F5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work